Sqi Diagnostics Stock Cash Per Share
| SQIDFDelisted Stock | USD 0.01 0.00 0.00% |
SQI Diagnostics fundamentals help investors to digest information that contributes to SQI Diagnostics' financial success or failures. It also enables traders to predict the movement of SQI Pink Sheet. The fundamental analysis module provides a way to measure SQI Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SQI Diagnostics pink sheet.
SQI |
SQI Diagnostics Company Cash Per Share Analysis
SQI Diagnostics' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current SQI Diagnostics Cash Per Share | 0.01 X |
Most of SQI Diagnostics' fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SQI Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, SQI Diagnostics has a Cash Per Share of 0.01 times. This is 99.77% lower than that of the Health Care Equipment & Supplies sector and 99.73% lower than that of the Health Care industry. The cash per share for all United States stocks is 99.8% higher than that of the company.
SQI Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SQI Diagnostics' direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of SQI Diagnostics could also be used in its relative valuation, which is a method of valuing SQI Diagnostics by comparing valuation metrics of similar companies.SQI Diagnostics is currently under evaluation in cash per share category among its peers.
SQI Fundamentals
| Return On Equity | -12.54 | |||
| Return On Asset | -0.94 | |||
| Profit Margin | (2.29) % | |||
| Operating Margin | (1.71) % | |||
| Current Valuation | 34.24 M | |||
| Shares Outstanding | 406.25 M | |||
| Shares Owned By Insiders | 51.02 % | |||
| Shares Owned By Institutions | 24.31 % | |||
| Price To Earning | (2.35) X | |||
| Price To Book | 16.12 X | |||
| Price To Sales | 3.91 X | |||
| Revenue | 8.1 M | |||
| Gross Profit | 3.1 M | |||
| EBITDA | (12.12 M) | |||
| Net Income | (18.52 M) | |||
| Cash And Equivalents | 3.96 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 6.3 M | |||
| Debt To Equity | 4.64 % | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (9.82 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 21 | |||
| Beta | -0.0648 | |||
| Market Capitalization | 34.43 M | |||
| Total Asset | 9.31 M | |||
| Retained Earnings | (55.6 M) | |||
| Working Capital | 1.09 M | |||
| Current Asset | 1.67 M | |||
| Current Liabilities | 584 K | |||
| Z Score | -7.3 | |||
| Net Asset | 9.31 M |
About SQI Diagnostics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SQI Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SQI Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SQI Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in SQI Pink Sheet
If you are still planning to invest in SQI Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SQI Diagnostics' history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |